The DOI matches its Crossref record; 260 of the 260 references it cites were found in a registry or an index.
Candida Infections and Therapeutic Strategies: Mechanisms of Action for Traditional and Alternative Agents
Open accessAbstract
The Candida genus comprises opportunistic fungi that can become pathogenic when the immune system of the host fails. Candida albicans is the most important and prevalent species. Polyenes, fluoropyrimidines, echinocandins, and azoles are used as commercial antifungal agents to treat candidiasis. However, the presence of intrinsic and developed resistance against azole antifungals has been extensively documented among several Candida species. The advent of original and re-emergence of classical fungal diseases have occurred as a consequence of the development of the antifungal resistance phenomenon. In this way, the development of new satisfactory therapy for fungal diseases persists as a major challenge of present-day medicine. The design of original drugs from traditional medicines provides new promises in the modern clinic. The urgent need includes the development of alternative drugs that are more efficient and tolerant than those traditional already in use. The identification of new substances with potential antifungal effect at low concentrations or in combination is also a possibility. The present review briefly examines the infections caused by Candida species and focuses on the mechanisms of action associated with the traditional agents used to treat those infections, as well as the current understanding of the molecular basis of resistance development in these fungal species. In addition, this review describes some of the promising alternative molecules and/or substances that could be used as anticandidal agents, their mechanisms of action, and their use in combination with traditional drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–260 of 260
Phenylpropanoids of Plant Origin as Inhibitors of Biofilm Formation by Candida albicans
Raut, J. S., Shinde, R. B., Chauhan, N. M., & Karuppayil, S. M. (2014) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1402.02056 · Cited by 49
Chaturvedi, V. P., Ramani, R., Andes, D. R., Diekema, D. J., Pfaller, M. A., Ghannoum, M. A., Knapp, C. C., Lockhart, S. R., Ostrosky-Zeichner, L. L., Walsh, T. J., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01510-09 · Cited by 48
Evaluation of Antimicrobial and Wound Healing Potential ofJusticia flavaandLannea welwitschii
Agyare, C., Bempah, S. B., Boakye, Y. D., Ayande, P. G., Adarkwah‐Yiadom, M., & Mensah, K. B. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/632927 · Cited by 47
Costa, C., Ponte, A., Pais, P., Santos, R., Cavalheiro, M., Yaguchi, T., Chibana, H., & Teixeira, M. C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0135110 · Cited by 46
Echinocandins: Are They All The Same?
Mukherjee, P. K., Sheehan, D. F., Puzniak, L., Schlamm, H. T., & Ghannoum, M. A. (2011) · Journal of Chemotherapy · doi:10.1179/joc.2011.23.6.319 · Cited by 46
Antifungal effects of Ellagitannin isolated from leaves of Ocotea odorifera (Lauraceae)
Yamaguchi, M. U., Garcia, F. P., Cortez, D. A. G., Ueda‐Nakamura, T., Filho, B. P. D., & Nakamura, C. V. (2010) · Antonie van Leeuwenhoek · doi:10.1007/s10482-010-9516-3 · Cited by 46
Kaur, R., Dhakad, M. S., Goyal, R., Haque, A., & Mukhopadhyay, G. (2016) · Journal of Global Infectious Diseases · doi:10.4103/0974-777x.192969 · Cited by 46
Puri, N., Krishnamurthy, S., Habib, S., Hasnain, S. E., Goswami, S. K., & Prasad, R. (1999) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1999.tb08798.x · Cited by 45
Isa, A. I., Awouafack, M. D., Dzoyem, J. P., Aliyu, M., Magaji, R. A., Ayo, J. O., & Eloff, J. N. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-456 · Cited by 44
Candida Biofilms: Is Adhesion Sexy?
Soll, D. R. (2008) · Current Biology · doi:10.1016/j.cub.2008.07.014 · Cited by 44
Kusch, H., Biswas, K., Schwanfelder, S., Engelmann, S., Rogers, P. D., Hecker, M., & Morschhäuser, J. (2004) · Molecular Genetics and Genomics · doi:10.1007/s00438-004-0984-x · Cited by 44
Minooeianhaghighi, M., Sepehrian, L., & Shokri, H. (2016) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2016.09.002 · Cited by 44
He, X., Ma, Y., Yi, G., Wu, J., Zhou, L., & Guo, H. (2017) · Letters in Applied Microbiology · doi:10.1111/lam.12711 · Cited by 41
Razzaghi‐Abyaneh, M., Sadeghi, G., Zeinali, E., Alirezaee, M., Shams‐Ghahfarokhi, M., Amani, A., Mirahmadi, R., & Tolouei, R. (2014) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2014.01.004 · Cited by 41
The cellular and molecular defense mechanisms of the Candida yeasts against azole antifungal drugs
Noël, T. (2012) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2012.04.004 · Cited by 41
In VivoandIn VitroAcquisition of Resistance to Voriconazole by Candida krusei
Ricardo, E., Miranda, I. M., Faria‐Ramos, I., Silva, R. M., Rodrigues, A. G., & Pina‐Vaz, C. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02603-14 · Cited by 40
Armengou, A., Hurtado, O., Leira, R., Obón, M., Pascual, C., Moro, M. Á., Lizasoaín, I., Castillo, J., & Dávalos, A. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000080651.64357.c6 · Cited by 40
Histatin 5 inhibits adhesion of C. albicans to Reconstructed Human Oral Epithelium
Moffa, E. B., Mussi, M. C. M., Xiao, Y., Garrido, S. S., Machado, M. A. D. A. M., Giampaolo, E. T., & Siqueira, W. L. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00885 · Cited by 39
How to treat fungal infections in ICU patients
Matthaiou, D. K., Christodoulopoulou, T. C., & Dimοpoulos, G. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0934-8 · Cited by 39
Candidíase vulvovaginal: fatores predisponentes do hospedeiro e virulência das leveduras
Álvares, C. A., Svidzinski, T. I. E., & Consolaro, M. E. L. (2007) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.1590/s1676-24442007000500004 · Cited by 39
Cools, T. L., Struyfs, C., Drijfhout, J. W., Kucharíková, S., Romero, C. L., Dijck, P. V., Ramada, M. H. S., Bloch, C., Cammue, B. P. A., & Thevissen, K. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02051 · Cited by 39
van der Does, A. M., Joosten, S. A., Vroomans, E., Bogaards, S. J. P., van Meijgaarden, K. E., Ottenhoff, T. H. M., van Dissel, J. T., & Nibbering, P. H. (2012) · Journal of Innate Immunity · doi:10.1159/000332941 · Cited by 37
Chemical Composition and Biological Activity of Centaurea baseri: New Species from Turkey
Köse, Y. B., İşcan, G., Göğer, F., Akalın, G., Demırcı, B., & Başer, K. H. C. (2016) · Chemistry & Biodiversity · doi:10.1002/cbdv.201600070 · Cited by 35
Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans
Chen, C.-G., Yang, Y.-L., Tseng, K., Shih, H., Liou, C., Lin, C.-C., & Lo, H. (2009) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.06.003 · Cited by 34
Serena, C., Fernández-Torres, B., Pastor, F. J., Trilles, L., Lazéra, M. D. S., NOLARD, N., & Guarro, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2994-2996.2005 · Cited by 34
Pereira, A. M. S., Hernandes, C., Pereira, S. I. V., Bertoni, B. W., França, S. D. C., Pereira, P. S., & Contini, S. H. T. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.10.023 · Cited by 33
Gualco, L., Debbia, E. A., Bandettini, R., Pescetto, L., Cavallero, A., Ossi, M. C., Schito, A. M., & Marchese, A. E. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.08.047 · Cited by 33
Candida spp. bloodstream infection: influence of antifungal treatment on outcome
Ortega, M., Marco, F., Soriano, À., Almela, M., Martínez, J. A., Pitart, C., & Mensa, J. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp495 · Cited by 33
Plant Natural Products as a Potential Source for Antibacterial Agents: Recent Trends
Shahid, M., Shahzad, A., Sobia, F., Sahai, A., Tripathi, T., Singh, A. T., Khan, H. M., & Umesh (2009) · Anti-Infective Agents · doi:10.2174/187152109788680199 · Cited by 33
Ren, B., Dai, H., Pei, G., Tong, Y., Zhuo, Y., Yang, N., Su, M.-Y., Huang, P., Yang, Y., & Zhang, L. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-5425-5 · Cited by 32
Sharifzadeh, A., Khosravi, A., Shokri, H., & Sharafi, G. (2015) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2015.03.008 · Cited by 31
Efg1 Involved in Drug Resistance by Regulating the Expression of ERG3 in Candida albicans
Lo, H., Wang, J.-S., Lin, C., Chen, C.-G., Hsiao, T.-Y., Hsu, C.-T., Su, C.-L., Fann, M., Ching, Y.-T., & Yang, Y.-L. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1213-1215.2005 · Cited by 30
Candida albicans infection inhibits macrophage cell division and proliferation
Lewis, L. E., Bain, J. M., Lowes, C., Gow, N. A. R., & Erwig, L. (2012) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2012.05.007 · Cited by 30
Epidemiology of Echinocandin Resistance in Candida
Grossman, N. T., Chiller, T. M., & Lockhart, S. R. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0209-7 · Cited by 30
Our 2014 approach to candidaemia
Koehler, P. A., Tacke, D., & Cornely, O. A. (2014) · Mycoses · doi:10.1111/myc.12207 · Cited by 30
Antifungal activity of acetone extracts from Punica granatum L., Quercus suber L. and Vicia faba L.
Akroum, S. (2016) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2016.10.004 · Cited by 30
The effect of histatin 5, adsorbed on PMMA and hydroxyapatite, on Candida albicans colonization
Vukosavljevic, D., Custódio, W., Cury, A. A. D. B., & Siqueira, W. L. (2012) · Yeast · doi:10.1002/yea.2925 · Cited by 29
Martins, N. A., Barros, L., Henriques, M., Silva, S. M., & Ferreira, I. C. F. R. (2015) · BioMed Research International · doi:10.1155/2015/247382 · Cited by 29
Voriconazole-associated visual disturbances and hallucinations
Bayhan, G. İ., Garipardıç, M., Karaman, K., et al. (2015) · Cutaneous and Ocular Toxicology · doi:10.3109/15569527.2015.1020544 · Cited by 29
Ngouana, T. K., Mbouna, C. D. J., Toghueo, R. M. K., Tchuenmogne, M. A. T., Menkem, E. Z., Ngouana, V., Mallié, M., Bertout, S., & Boyom, F. F. (2015) · Medicines · doi:10.3390/medicines2030220 · Cited by 28
Gavanji, S., Zaker, S. R., nejad, Z. G., Bakhtari, A., Bidabadi, E. S., & Larki, B. (2015) · Integrative Medicine Research · doi:10.1016/j.imr.2015.01.003 · Cited by 28
Selected mechanisms of molecular resistance of Candida albicans to azole drugs
Gołąbek, K., Strzelczyk, J. K., Owczarek, A., Cuber, P., Ślemp-Migiel, A., & Wiczkowski, A. (2015) · Acta Biochimica Polonica · doi:10.18388/abp.2014_940 · Cited by 26
Avijgan, M., Mahboubi, M., Nasab, M. M., Nia, E. A., & Yousefi, H. A. (2014) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2014.01.116 · Cited by 26
Moraes, R. C., Lana, A. J. D., Kaiser, S., Carvalho, Â. R., de Oliveira, L. F. S., Fuentefría, A. M., & Ortega, G. G. (2015) · Industrial Crops and Products · doi:10.1016/j.indcrop.2015.01.033 · Cited by 26
Wang, J., Yang, Y.-L., Wu, C.-J., Ouyang, K. J., Tseng, K., Chen, C.-G., Wang, H., & Lo, H. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46650-0 · Cited by 26
Li, S. Y., Yang, Y., CHEN, K. W., Cheng, H.-H., Chiou, C., Wang, T. H., Lauderdale, T. L., Hung, C., & Lo, H. (2005) · Epidemiology and Infection · doi:10.1017/s0950268805004905 · Cited by 26
A new class of pegylated plasmonic liposomes: Synthesis and characterization
Stiufiuc, R. I., Iacoviță, C., STIUFIUC, G., Florea, A., Achim, M., & Lucaciu, C. M. (2014) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2014.09.023 · Cited by 25
Antifungal effects of synthetic human β-defensin 3-C15 peptide
Lim, S.-M., Ahn, K., Kim, C., Kum, J., Perinpanayagam, H., Gu, Y., Yoo, Y., Chang, S., Han, S., Shon, W., et al. (2016) · Restorative Dentistry & Endodontics · doi:10.5395/rde.2016.41.2.91 · Cited by 23
Looi, C. Y., d'Silva, E. C., Seow, H. F., Rosli, R., Ng, K. P., & Chong, P. P. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.06.036 · Cited by 20
Nordin, M.-A.-F., Himratul-Aznita, W. H., Razak, F. B. A., & Musa, M. Y. (2014) · International Journal of Oral Science · doi:10.1038/ijos.2013.97 · Cited by 20
Strzelczyk, J. K., Ślemp-Migiel, A., Rother, M. B., Gołąbek, K., & Wiczkowski, A. (2013) · Acta Biochimica Polonica · doi:10.18388/abp.2013_2019 · Cited by 19
Congestive heart failure related to antifungal therapy with itraconazole
Vollenbroich, R., Maeder, M. T., & Weilenmann, D. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.12.057 · Cited by 17
Filho, J. R. N. C., Silva, T. F., Nobre, W. Q., de Souza, L. I. O., Figueiredo, C. S. S. E. S., de Figueiredo, R. C. B. Q., de Gusmão, N. B., Silva, M. V., da Silva, L. C. N., & Correia, M. T. D. S. (2017) · Pharmaceutical Biology · doi:10.1080/13880209.2017.1304427 · Cited by 17
Cuenca‐Estrella, M. (2010) · PubMed · Cited by 16
Antifungal Drug Resistance in Candida Species
Nagoba, B., Sheikh, N., Jahagirdar, V. L., & Kothadia, S. N. (2013) · Electronic Journal of General Medicine · doi:10.29333/ejgm/82217 · Cited by 16
Caban, M., Strapagiel, D., Dziadek, J., Korycka‐Machała, M., & Grzelak, A. (2016) · Current Microbiology · doi:10.1007/s00284-016-1039-3 · Cited by 13
Cuenca‐Estrella, M. (2010) · Revista española de quimioterapia. Suplemento · Cited by 12
THE QUALITATIVE IDENTIFICATION OF FREE AMINO ACIDS IN HUMAN VAGINAL FLUID
Gregoire, A. T., Lang, W. R., & Ward, K. (1959) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1960.tb40891.x · Cited by 12
Trypanocide, cytotoxic, and anti-Candida activities of natural products: Hyptis martiusii Benth.
Santos, K. K. A., Matias, E. F. F., Sobral-Souza, C. E., Tintino, S. R., Morais‐Braga, M. F. B., Guedes, G. M. D. M., Rolón, M. S., Coronel, C., Alfonso, J., Vega, C., et al. (2013) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2013.06.001 · Cited by 11
Raman, S. B., Nguyen, M. H., Cheng, S., Badrane, H., Iczkowski, K. A., Wegener, M., Gaffen, S. L., Mitchell, A. P., & Clancy, C. J. (2013) · Infection and Immunity · doi:10.1128/iai.00743-12 · Cited by 10
Cited by
Antifungal drug-resistance mechanisms in Candida biofilms
Kaur, J., & Nobile, C. J. (2023) · Current Opinion in Microbiology · doi:10.1016/j.mib.2022.102237 · Cited by 261
Mechanism of Candida pathogenesis: Revisiting the vital drivers
Mba, I. E., & Nweze, E. I. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03912-w · Cited by 143
Antimicrobial Activities of Natural Bioactive Polyphenols
Mandal, M. K., & Domb, A. J. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16060718 · Cited by 141
Anti-fungal properties and mechanisms of melittin
Memariani, H., & Memariani, M. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10701-0 · Cited by 58
Hodges, M. R., Ople, E., Wedel, P., Shaw, K. J., Jakate, A., Kramer, W. G., Marle, S. V., van Hoogdalem, E.-J., & Tawadrous, M. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01623-22 · Cited by 52
Metadata
- Authors
- de Oliveira Santos, G. C., Vasconcelos, C. C., Lopes, A. J. O., de Sousa Cartágenes, M. D. S., Filho, A. K. D. B., do Nascimento, F. R. F., Ramos, R. M., Pires, E. R. R. B., de Andrade, M. S., Rocha, F. M. G., & de Andrade Monteiro, C.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2018-07-03
- Volume
- 9
- Pages
- 1351-1351
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2806610516
- Cited by
- 350
- References
- 260
- FWCI
- 17.81
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.